Differential diagnosis of parkinsonism based on deep metabolic imaging indices.

Wu, Ping; Zhao, Yu; Wu, Jianjun; Brendel, Matthias; Lu, Jiaying; Ge, Jingjie; Bernhardt, Alexander; Li, Ling; Alberts, Ian; Katzdobler, Sabrina; Yakushev, Igor; Hong, Jimin; Xu, Qian; Sun, Yimin; Liu, Fengtao; Levin, Johannes; Hoeglinger, Guenter; Bassetti, Claudio; Guan, Yihui; Oertel, Wolfgang H; ... (2022). Differential diagnosis of parkinsonism based on deep metabolic imaging indices. (In Press). Journal of nuclear medicine Society of Nuclear Medicine 10.2967/jnumed.121.263029

[img]
Preview
Text
jnumed.121.263029.full.pdf - Accepted Version
Available under License Publisher holds Copyright.

Download (2MB) | Preview

The clinical presentations of early idiopathic Parkinson's disease (PD) substantially overlap with those of atypical parkinsonian syndromes like multiple system atrophy (MSA) and progressive supranuclear palsy (PSP). This study aimed to develop metabolic imaging indices based on deep learning to support the differential diagnosis of these conditions. Methods: A benchmark Huashan parkinsonian PET imaging (HPPI, China) database including 1275 parkinsonian patients and 863 non-parkinsonian subjects with 18F-FDG PET images was established to support artificial intelligence development. A 3D deep convolutional neural network was developed to extract deep metabolic imaging (DMI) indices, which was blindly evaluated in an independent cohort with longitudinal follow-up from the HPPI, and an external German cohort of 90 parkinsonian patients with different imaging acquisition protocols. Results: The proposed DMI indices had less ambiguity space in the differential diagnosis. They achieved sensitivities of 98.1%, 88.5%, and 84.5%, and specificities of 90.0%, 99.2%, and 97.8% for the diagnosis of PD, MSA, and PSP in the blind test cohort. In the German cohort, They resulted in sensitivities of 94.1%, 82.4%, 82.1%, and specificities of 84.0%, 99.9%, 94.1% respectively. Employing the PET scans independently achieved comparable performance to the integration of demographic and clinical information into the DMI indices. Conclusion: The DMI indices developed on the HPPI database show potential to provide an early and accurate differential diagnosis for parkinsonism and is robust when dealing with discrepancies between populations and imaging acquisitions.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Radiology, Neuroradiology and Nuclear Medicine (DRNN) > Clinic of Nuclear Medicine
04 Faculty of Medicine > Department of Head Organs and Neurology (DKNS) > Clinic of Neurology

UniBE Contributor:

Zhao, Yu; Lu, Jiaying; Alberts, Ian Leigh; Hong, Jimin; Bassetti, Claudio; Rominger, Axel Oliver and Shi, Kuangyu

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0161-5505

Publisher:

Society of Nuclear Medicine

Language:

English

Submitter:

Pubmed Import

Date Deposited:

07 Mar 2022 10:03

Last Modified:

07 Mar 2022 10:06

Publisher DOI:

10.2967/jnumed.121.263029

PubMed ID:

35241481

Uncontrolled Keywords:

Molecular Imaging Neurology PET/CT Parkinsons disease atypical parkinsonian syndrome deep learning deep metabolic imaging indices differential diagnosis

BORIS DOI:

10.48350/166596

URI:

https://boris.unibe.ch/id/eprint/166596

Actions (login required)

Edit item Edit item
Provide Feedback